@xconomy.com 3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com 4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com 4 years ago
Microsoft, Providence Tie-up Focuses on Cloud Tech in Healthcare
@xconomy.com 4 years ago
Providence St. Joseph to Buy Wisconsin Health IT Consultant Bluetree
@xconomy.com 4 years ago
HAP Partners With Livongo on Tech-Enabled Diabetes Compliance Program
@xconomy.com 4 years ago
Seattle’s TransformativeMed Carves Out Niche in Medical Specialties
@xconomy.com 5 years ago
Xealth Gets $11M, Aims to Be Surescripts of Digital Health Services
@xconomy.com 5 years ago
Seattle Venture Capital Watch: Modumetal, Illumagear, HaptX & More
@xconomy.com 5 years ago
Seattle Venture Capital Watch: Modumetal, Illumagear, HaptX & More
@xconomy.com 5 years ago
Providence St. Joseph Acquires Seattle Blockchain Startup Lumedic
@xconomy.com 5 years ago
Providence Ventures Raises $150M to Invest in Healthtech Startups
@xconomy.com 5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com 5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
@xconomy.com 5 years ago
Circulation CEO Talks Sale to LogistiCare & Amazon’s Healthcare Play
@xconomy.com 5 years ago
In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect